Citigroup’s IGM Biosciences IGMS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.1K | Sell |
8,988
-2,726
| -23% | -$3.05K | ﹤0.01% | 4449 |
|
|
2025
Q1 | $13.5K | Sell |
11,714
-537
| -4% | -$618 | ﹤0.01% | 4379 |
|
|
2024
Q4 | $74.9K | Buy |
12,251
+1,286
| +12% | +$7.86K | ﹤0.01% | 4113 |
|
|
2024
Q3 | $181K | Buy |
10,965
+7,645
| +230% | +$126K | ﹤0.01% | 3646 |
|
|
2024
Q2 | $22.8K | Buy |
3,320
+796
| +32% | +$5.47K | ﹤0.01% | 4228 |
|
|
2024
Q1 | $24.4K | Buy |
2,524
+637
| +34% | +$6.15K | ﹤0.01% | 4220 |
|
|
2023
Q4 | $15.7K | Buy |
1,887
+1,450
| +332% | +$12K | ﹤0.01% | 4312 |
|
|
2023
Q3 | $3.65K | Sell |
437
-3,945
| -90% | -$32.9K | ﹤0.01% | 4063 |
|
|
2023
Q2 | $40.4K | Buy |
4,382
+3,451
| +371% | +$31.9K | ﹤0.01% | 4074 |
|
|
2023
Q1 | $12.8K | Buy |
931
+236
| +34% | +$3.24K | ﹤0.01% | 3997 |
|
|
2022
Q4 | $11.8K | Sell |
695
-46
| -6% | -$782 | ﹤0.01% | 4084 |
|
|
2022
Q3 | $17K | Sell |
741
-574
| -44% | -$13.2K | ﹤0.01% | 4074 |
|
|
2022
Q2 | $23K | Sell |
1,315
-1,379
| -51% | -$24.1K | ﹤0.01% | 4222 |
|
|
2022
Q1 | $72K | Sell |
2,694
-41,668
| -94% | -$1.11M | ﹤0.01% | 3881 |
|
|
2021
Q4 | $1.3M | Buy |
44,362
+24,037
| +118% | +$705K | ﹤0.01% | 2296 |
|
|
2021
Q3 | $1.34M | Sell |
20,325
-20,267
| -50% | -$1.33M | ﹤0.01% | 2193 |
|
|
2021
Q2 | $3.38M | Sell |
40,592
-6,512
| -14% | -$542K | ﹤0.01% | 1728 |
|
|
2021
Q1 | $3.61M | Buy |
47,104
+43,212
| +1,110% | +$3.31M | ﹤0.01% | 1568 |
|
|
2020
Q4 | $343K | Buy |
3,892
+3,354
| +623% | +$296K | ﹤0.01% | 2888 |
|
|
2020
Q3 | $40K | Sell |
538
-4,781
| -90% | -$355K | ﹤0.01% | 3597 |
|
|
2020
Q2 | $388K | Buy |
5,319
+3,839
| +259% | +$280K | ﹤0.01% | 2723 |
|
|
2020
Q1 | $83K | Buy |
1,480
+486
| +49% | +$27.3K | ﹤0.01% | 3415 |
|
|
2019
Q4 | $38K | Buy |
+994
| New | +$38K | ﹤0.01% | 4143 |
|